Movement Disorders (revue) - Exploration (Accueil)

Index « Titre (en) » - entrée « administration »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
administered < administration < administrative  Facettes :

List of bibliographic references indexed by administration

Number of relevant bibliographic references: 30.
[20-40] [0 - 20][0 - 30]
Ident.Authors (with country if any)Title
005C02 (1994) S. Rose [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Chronic administration does not alter the accumulation of L‐dopa into muscle
005D26 (1993) A. J. Hughes [Royaume-Uni] ; Susan Bishop [Royaume-Uni] ; Birgit Kleedorfer [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. Stern [Royaume-Uni]Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years
005D64 (1993) A. Ferbert [Allemagne] ; R. Biniek [Allemagne] ; J. Kindler [Allemagne] ; N. Maurin [Allemagne]Myoclonus and tremor induced acutely by administration of tumor necrosis factor in a patient with ehlers‐danlos syndrome
005E28 (1993) M. Guttman [Canada] ; G. Léger [Canada] ; A. Reches [Israël] ; A. Evans [Canada] ; H. Kuwabara [Canada] ; J. M. Cedarbaum [États-Unis] ; Gjedde [Canada]Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
005E49 (1993) A. J. Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. SternSubcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years
006422 (1989) Gibb [Royaume-Uni] ; M. Terruli [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
006493 (1989) W. R. G. Gibb ; M. Terruli ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner ; C. D. MarsdenThe evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
006525 (1988) S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni]The effect of carbidopa on plasma and muscle levels of L‐dopa, dopamine, and their metabolites following L‐dopa administration to rats
006667 (1986) V. Muradas [Espagne] ; E. Bazan [Espagne] ; J. J. Gervas [Espagne] ; M. A. Mena [Espagne] ; J. G. De Yebenes [Espagne, États-Unis]The effect of single and repeated administration of bromocriptine on monoamine metabolism in rat brain and [3H]spiroperidol binding to striatal membranes
006701 (1986) J. Garvey [Royaume-Uni] ; M. Petersen ; C. M. Waters ; S. P. Rose [Royaume-Uni] ; S. Hunt ; R. Briggs ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Administration of MPTP to the common marmoset does not alter cortical cholinergic function

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "administration" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "administration" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    administration
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024